Production has begun at Tekni- Plex's new manufacturing facility in Suzhou, China, near Shanghai. A grand opening event will take place on 19th September 2017.
Personal care community
As Tekni-Plex celebrates its 50th anniversary in 2017, the producer committed $15 mn (€12.4 mn) investment, to increase the Chinese facility's capabilities. These additional resources aim to help the growing needs of the Asia-Pacific (APAC) personal care and pharmaceutical markets.
The facility is designed to provide medical tubing solutions materials for a host of industries including the personal care and pharmaceutical sectors.
Tekni-Plex will now launch its recently-revealed silicone extrusion tubing and Colorite custom compounds for medical device applications to add creative applications to the personal care packaging segment.
The new facility, which boasts more than 13,000-square-metres of space, has started manufacturing products for Tekni-Plex's Natvar, Colorite and Action Technology business units.
Local officials will attend the launch event on 19th September 2017, along with Paul Young, Chief Executive Officer; Russell Hubbard, Vice President-International and General Manager; Ian Kenny, Global Managing Director, Colorite and Bob Donohue, General Manager of the company's Natvar business unit.
APAC manufacturing boost
This recent unveiling comes after a string of new production facility launches and revamps in China and APAC. Global companies head to the leading colour cosmetics and personal care nation as consumers show a preference for prestige and high-quality brands.
The move followed China Ministry of Finance’s decision to remove its consumption tax on its existing cosmetics and reduce it to 15% for luxury cosmetics.
In February 2017, Cosmax announced the opening of its new colour cosmetics facility to increase its production capabilities to 200 million cosmetics per year.
Then, Kao announced in June 2017 that it was making strides with its K20 plans by creating a new production facility in the Philippines for aroma chemicals for the fragrance sector.
Focusing on producing bioproducts for the personal care and fragrance markets, Amyris Biotech also revealed it had established advanced plans to launch a biorefinery with the government of Queensland Australia to support its Biofutures Acceleration Programme and provide supplies to the wider APAC markets.